Jonathan Wilson, MD
Family Medicine · Charlotte, NCNPI 1841602992
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,961 of the $2,354 with a category attached, or 83.3%. Stryker accounts for 83.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $1,462 and has fallen 87.7% since, to $179 in 2024.
Across 18 payments — averaging $130.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Viiv Healthcare Company$128
- AbbVie$109
- Exact Sciences$99
- Novo Nordisk$33
- Pfizer$23
Across 1 payment — averaging $832.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$833
What the payments were for
- Travel & lodging$1,96183%
- Food & beverage$37016%
- Education$231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 3 | $1,961 |
| Viiv Healthcare Company | 5 | $128 |
| AbbVie | 5 | $109 |
| Exact Sciences | 2 | $99 |
| Novo Nordisk | 2 | $33 |
| Pfizer | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,354 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 40 | $59,674 |
| OzempicSemaglutide | 35 | $43,336 |
| EliquisApixaban | 11 | $21,086 |
| TrulicityDulaglutide | 16 | $18,292 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 17 | $13,994 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,767 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,539 |
| Bupropion XlBupropion Hcl | 64 | $1,321 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $884 |
| Sevelamer Carbonate | 13 | $823 |
| Gabapentin | 50 | $796 |
| Atorvastatin Calcium | 119 | $714 |
| Diclofenac Sodium | 26 | $643 |
| Amlodipine Besylate | 123 | $607 |
| Omeprazole | 69 | $548 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $33 | $43,33635 claims |
| PfizerEliquis | $23 | $21,08611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Charlotte
- Kevin SodenCharlotte$558K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Thomas BarringerCharlotte$138K
- William LarsenCharlotte$74K
- William LongCharlotte$66K
- Steven BauerCharlotte$22K
- Tagbo EkwonuCharlotte$20K
- Rhett BrownCharlotte$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.